Driven to accelerate the Life Sciences industry through its current transformation, Michael has been at the forefront of navigating industry disruption since 2020. With drugs being developed faster, new ATMP modalities emerging, and evolving business operations, he has witnessed firsthand how digital technologies are reshaping the landscape. His expertise lies in harnessing these advancements to address industry challenges and drive impactful outcomes. Passionate about bridging the gap between visionary technologies and practical implementation, he enables organizations to integrate people and technology for accelerated progress and improvement in the Life Sciences sector.